Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discrepancies in Genetic Testing Procedures of BRCA1/2 Mutations: A National Survey Across China.

Molecular diagnosis & therapy - 1 Dec 2020

Wu Huanwen, Xu Binghe, Gao Qinglei, Zhou Xiaoyan, Shao Jianyong, Liang Zhiyong, Ma Ding

Abstract excerpt

International guidelines recommend BRCA testing for patients with breast and ovarian cancer. Little is known about the genetic testing practices of BRCA1/2 mutations in laboratories across China. This study was designed to assess the discrepancies in genetic testing procedures of BRCA1/2 mutations across China. An online survey was developed for depicting the BRCA1/2 testing landscape in China. Our results show...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to China

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Geography

Share to High-Throughput Nucleotide Sequencing

Share to Surveys and Questionnaires

Source

Identifiers

PMID: 32970304
DOI: 10.1007/s40291-020-00489-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discrepancies in Genetic Testing Procedures of BRCA1/2 Mutations: A National Survey Across China.PMID 32970304Read ↗

The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.Semantic proximity Read ↗

Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing SuggestionsSemantic proximity Read ↗

Comprehensive evaluation of BRCA1/2 variant interpretation ability among laboratories in China.Semantic proximity Read ↗

[China expert consensus on BRCA variant interpretation].Semantic proximity Read ↗

Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population.Semantic proximity Read ↗

Analysis and comparison of BRCA1/2 gene mutations in 310 cases of ovarian cancerSemantic proximity Read ↗

Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing.Semantic proximity Read ↗

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer PatientsSemantic proximity Read ↗

Prevalence and Spectrum of BRCA1/2 Germline Mutations in Women with Breast Cancer in China Based on Next-Generation Sequencing.Semantic proximity Read ↗

Comprehensive profiling of BRCA1 and BRCA2 variants in breast and ovarian cancer in Chinese patients.Semantic proximity Read ↗

The reliable assurance of detecting somatic mutations in cancer-related genes by next-generation sequencing: the results of external quality assessment in China.Semantic proximity Read ↗

Current practices and challenges in genetic testing and counseling for women with breast and ovarian cancer in AsiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.